CVE-2023-22868 Vulnerability Details

  /     /     /  

CVE-2023-22868 Metadata Quick Info

CVE Published: 17/02/2023 | CVE Updated: 02/08/2024 | CVE Year: 2023
Source: ibm | Vendor: IBM | Product: Aspera Faspex
Status : PUBLISHED

---

CVE-2023-22868 Description

IBM Aspera Faspex 4.4.1 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 244117.

Metrics

CVSS Version: 3.1 | Base Score: 5.4 MEDIUM
Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

l➤ Exploitability Metrics:
    Attack Vector (AV)* NETWORK
    Attack Complexity (AC)* LOW
    Privileges Required (PR)* LOW
    User Interaction (UI)* REQUIRED
    Scope (S)* CHANGED

l➤ Impact Metrics:
    Confidentiality Impact (C)* LOW
    Integrity Impact (I)* LOW
    Availability Impact (A)* NONE

Weakness Enumeration (CWE)

CWE-ID: CWE-79
CWE Name: CWE-79 Improper Neutralization of Input During Web Page Generation ( Cross-site Scripting )
Source: IBM

Common Attack Pattern Enumeration and Classification (CAPEC)

CAPEC-ID:
CAPEC Description:


Source: NVD (National Vulnerability Database).